Tevogen Bio Holdings (TVGN) Current Assets (2021 - 2026)

Tevogen Bio Holdings has reported Current Assets for 6 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 30.44% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 30.44% YoY), and the FY2025 full-year result was $1.5 million, down 34.78% from the prior year.
• Current Assets for Q1 2026 stood at $2.1 million, up from $1.5 million in the prior quarter.
• The five-year high for Current Assets was $3.5 million in Q3 2024, with the low at $97064.0 in Q1 2023.
• Historically, Current Assets has averaged $1.6 million across 5 years, with a median of $1.7 million in 2023.
• Annual changes were most pronounced in 2023 — Current Assets slumped 86.78% — and 2024, when it soared 2372.51%.
• Tevogen Bio Holdings' Current Assets stood at $274356.0 in 2022, then soared by 528.01% to $1.7 million in 2023, then surged by 37.02% to $2.4 million in 2024, then slumped by 34.78% to $1.5 million in 2025, then surged by 39.05% to $2.1 million in 2026.
• The last three Current Assets figures came in at $2.1 million (Q1 2026), $1.5 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.